Intracerebroventricular Cerliponase Alfa for CLN2 Disease: Clinical Practice Considerations from US Clinics

被引：0
|
作者：
de los Reyes, E.
Lehwald, L.
Wang, R.
Augustine, E.
Berry-Kravis, E.
Butler, K.
Cormier, N.
Demarest, S.
Lu, S.
Madden, J.
Olaya, J.
See, S.
Vierhile, A.
Yang, A.
Leal-Pardinas, F.
机构：
来源：
ANNALS OF NEUROLOGY | 2019年 / 86卷
关键词：
Rare Diseases;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
205
引用
收藏
页码：S136 / S136
页数：1
相关论文
共 50 条
  • [1] Intracerebroventricular cerliponase alfa for CLN2 disease: Clinical practice considerations from US clinics
    Wang, Raymond Y.
    de los Reyes, Emily
    Lehwald, Lenora
    Augustine, Erika
    Berry-Kravis, Elizabeth
    Butler, Karen
    Cormier, Natalie
    Demarest, Scott
    Lu, Sam
    Madden, Jacqueline
    Olaya, Joffre
    See, Susan
    Vierhile, Amy
    Wheless, James
    Yang, Amy
    Cohen-Pfeffer, Jessica
    Chu, Dorna
    Leal-Pardinas, Fernanda
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S158 - S158
  • [2] Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics
    Reyes, Emily de los
    Lehwald, Lenora
    Augustine, Erika F.
    Berry-Kravis, Elizabeth
    Butler, Karen
    Cormier, Natalie
    Demarest, Scott
    Lu, Sam
    Madden, Jacqueline
    Olaya, Joffre
    See, Susan
    Vierhile, Amy
    Wheless, James W.
    Yang, Amy
    Cohen-Pfeffer, Jessica
    Chu, Dorna
    Leal-Pardinas, Fernanda
    Wang, Raymond Y.
    PEDIATRIC NEUROLOGY, 2020, 110 : 64 - 70
  • [3] Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration
    Kim, Aryun
    Grover, Anita
    Hammon, Kevin
    de Hart, Greg
    Slasor, Peter
    Cherukuri, Anu
    Ajayi, Temitayo
    Jacoby, David
    Schulz, Angela
    Specchio, Nicola
    de Los Reyes, Emily
    Gissen, Paul
    Henshaw, Joshua W.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (02): : 635 - 644
  • [4] Cerliponase alfa for CLN2 disease, a promising therapy
    Aylward, Shawn C.
    Pindrik, Jonathan
    Abreu, Nicolas J.
    Cherny, W. Bruce
    O'Neal, Matthew
    de Los Reyes, Emily
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (11): : 445 - 454
  • [5] Study of Intraventricular Cerliponase Alfa for CLN2 Disease
    Schulz, Angela
    Ajayi, Temitayo
    Specchio, Nicola
    de Los Reyes, Emily
    Gissen, Paul
    Ballon, Douglas
    Dyke, Jonathan P.
    Cahan, Heather
    Slasor, Peter
    Jacoby, David
    Kohlschutter, Alfried
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (20): : 1898 - 1907
  • [6] Dose selection for intracerebroventricular cerliponase alfa in children with CLN2 disease, translation from animal to human in a rare genetic disease
    Hammon, Kevin
    de Hart, Greg
    Vuillemenot, Brian R.
    Kennedy, Derek
    Musson, Don
    O'Neill, Charles A.
    Katz, Martin L.
    Henshaw, Joshua W.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (05): : 1810 - 1821
  • [7] Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study
    Cherukuri, Anu
    Cahan, Heather
    de Hart, Greg
    Van Tuyl, Andrea
    Slasor, Peter
    Bray, Laurie
    Henshaw, Joshua
    Ajayi, Temitayo
    Jacoby, Dave
    O'Neill, Charles A.
    Schweighardt, Becky
    CLINICAL IMMUNOLOGY, 2018, 197 : 68 - 76
  • [8] Psychometric Validation of the CLN2 Quality of Life Questionnaire in Participants with CLN2 Disease Treated with Cerliponase Alfa
    Due, Christina
    Quinn, Jennifer
    Gissen, Paul
    Schulz, Angela
    Specchio, Nicola
    de los Reyes, Emily
    Butt, Thomas
    HEALTHCARE, 2024, 12 (22)
  • [9] Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfa
    Schulz, Angela
    Schwering, Christoph
    Wibbeler, Eva
    Westermann, Lena Marie
    Hagenah, Luca
    Lezius, Susanne
    Jha, Ashok
    Hunt, Abigail
    Slasor, Peter
    Reisewitz, Pascal
    Nickel, Miriam
    FRONTIERS IN NEUROLOGY, 2025, 16
  • [10] Cerliponase Alfa for the Treatment of Atypical Phenotypes of CLN2 Disease: A Retrospective Case Series
    Wibbeler, Eva
    Wang, Raymond
    de los Reyes, Emily
    Specchio, Nicola
    Gissen, Paul
    Guelbert, Norberto
    Nickel, Miriam
    Schwering, Christoph
    Lehwald, Lenora
    Trivisano, Marina
    Lee, Laura
    Amato, Gianni
    Cohen-Pfeffer, Jessica
    Shediac, Renee
    Leal-Pardinas, Fernanda
    Schulz, Angela
    JOURNAL OF CHILD NEUROLOGY, 2021, 36 (06) : 468 - 474
12345